↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

10 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Alemtuzumab  18件: Alemtuzumab; Alemtuzumab (gz402673); Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection [lemtrada]; Alemtuzumab (campath); Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab and rituximab; Alemtuzumab, rituximab; Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D02802   -   -   17件:
13,
15,
19,
20,
46,
49,
51,
60,
63,
65,
85,
96,
164,
234,
284,
285,
326
 2   Anakinra  8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra and peg stnf-r1; Kineret® (anakinra); Response to anakinra associated with methotrexate; Anakinra / kineret; Kineret® or anakinra;   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   17件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
65,
84,
86,
106,
107,
266,
299
 3   Arimoclomol  1件: Arimoclomol;   D11374   -   -   3件:
2,
15,
19
 4   Bimagrumab  3件: Bimagrumab; Bym338 (bimagrumab); Bym338/bimagrumab;   D10620   -   -   1件:
15
 5   Botulinum toxin type A  3件: Botulinum toxin type a; Clostridium botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle;   D00783   1件: SNAP25   1件: Synaptic vesicle cycle   13件:
2,
5,
6,
7,
13,
15,
17,
36,
51,
70,
113,
149,
226
 6   Etanercept  39件: Etanercept; Enbrel (etanercept); Etanercept 50 mg solution for injection; 50 mg etanercept; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Commercial formulation etanercept; Etanercept (enbrel); Etanercept (enbreltm); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept / autoinjector a; Etanercept 50mg; Etanercept biosimilar; Etanercept liquid; Etanercept or adalimumab; Etanercept pre-filled syringe sq injection; Etanercept treatment; Etanercept via autoinjector a; Etanercept via autoinjector b; Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Methotrexate - etanercept - prednisolone arm; New formulation etanercept; Phase 1: etanercept; Reumatocept (etanercept); Sb4 (etanercept biosimilar); Sb4 (proposed biosimilar to etanercept); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Etanercept, methotrexate, prednisolone; Adalimumab, etanercept, golimumab or infliximab; Etanercept (50mg per week); Etanercept (50mg per week, for 2 weeks); Etanercept (50mg per week, for 4 weeks); Etanercept (full-dose); Etanercept (half-dose); Tapering or discontinuation of etanercept;   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
15,
28,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298
 7   Natalizumab  12件: Bg00002 (natalizumab); Bg00002-e (natalizumab high titer); Bg0002 (natalizumab); Natalizumab; Natalizumab (bg00002); Natalizumab (ntz); Natalizumab (tysabri); Natalizumab for iv infusion; Natalizumab for subcutaneous injection; Natalizumab treatment; Tysabri ® (natalizumab); Tysabri® (natalizumab);   D06886   1件: ITGA4   2件: ECM-receptor interaction, Leukocyte transendothelial migration   6件:
13,
15,
25,
46,
63,
96
 8   Pioglitazone  6件: Pioglitazone; Pioglitazone and tretinoin; Tretinoin and pioglitazone hcl; Actos (pioglitazone); Pioglitazone 15 mg; Pioglitazone or metformin;   D00945
 D08378 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299
 9   Simvastatin  16件: Simvastatin; Simvastatine; Encapsulated simvastatin tablets; Simvastatin 40 mg film-coated tablets; Simvastatin alternova; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; Simvastatin 20mg/5ml oral suspension; Ezetimibe+simvastatin drug combination; Simvastatin 40mg; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatin treatment for 28 days; Simvastatin susp.;   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310
 10   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331